Spinal Matrix Metalloproteinase 8 Regulates Pain after Peripheral Trauma by Tajerian, Maral & Clark, J. David
City University of New York (CUNY) 
CUNY Academic Works 
Publications and Research Queens College 
2019 
Spinal Matrix Metalloproteinase 8 Regulates Pain after Peripheral 
Trauma 
Maral Tajerian 
CUNY Queens College 
J. David Clark 
Stanford University 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/qc_pubs/472 
Discover additional works at: https://academicworks.cuny.edu 
This work is made publicly available by the City University of New York (CUNY). 
Contact: AcademicWorks@cuny.edu 
S HO RT R E P O RT
Spinal matrix metalloproteinase 8 regulates pain
after peripheral trauma
This article was published in the following Dove Press journal:
Journal of Pain Research
Maral Tajerian1
J David Clark2–4
1Department of Biology, Queens College,
City University of New York, Queens,
NY 11367, USA; 2Veterans Affairs Palo
Alto Health Care System, Palo Alto, CA
94304, USA; 3Department of
Anesthesiology, Stanford University
School of Medicine, Stanford, CA 94305,
USA; 4Palo Alto Veterans Institute for
Research, Palo Alto, CA 94304, USA
Abstract: It is well documented that pain chronification requires a host of plastic mechan-
isms at the spinal cord (SC) level, including alterations in neuronal and glial structure and
function. Such cellular plasticity necessitates the existence of a plastic extracellular matrix
(ECM). Here, we describe a key role for ECM remodeling in the regulation of chronic pain
following peripheral injury. Three weeks following tibia fracture in mice, we show increased
levels of MMP8 in the SC. Furthermore, we show that the pharmacological or genetic
downregulation of MMP8 ameliorates the pain phenotype observed after injury. These results
delineate an extracellular mechanism for pain chronification, thereby improving our mechan-
istic understanding of pain and providing novel therapeutic venues that go beyond targeting
individual cell types.
Keywords: spinal cord, chronic pain, matrix metalloproteinase 8, mouse model, mechanical
allodynia, shRNA
Introduction
The sensation of pain carries out a vital protective role against tissue damage. In
many cases, however, the pain outlasts the original injury and itself becomes
a pathology that is typically resistant to classical forms of treatment. This concept
of pain chronification refers to sensory events that parallel peripheral trauma and
gradually alter the central nervous system (CNS), thereby augmenting injury-
associated pain or resulting in the experience of pain in the absence of any
injury.1 These CNS alterations encompass aberrant activity in the spinal cord
(SC) dorsal horn neurons as well as hyperactive glial cells, which contribute to
the pathologic somatosensory signals that are conveyed to the brain.2
While most studies have focused on cellular plasticity and chronic pain, we have
recently described a key role for the hippocampal extracellular matrix (ECM) in
regulating pain and memory function following peripheral injury in mice.3 In
particular, our biophysical analyses showed decreased ECM rigidity and dysregu-
lated microarchitecture that were paralleled by biochemical changes in various
ECM components and enzymes, including increased levels of matrix metallopro-
teinase 8 (MMP8), also known as collagenase-2 or neutrophil collagenase.
Furthermore, we showed that normalizing MMP8 upregulation is sufficient in
reversing the behavioral and cellular alterations observed after injury.
The current manuscript aims at translating these findings to spinal tissues,
a direction that stems from well-characterized SC plasticity in pain. In our rodent
model of chronic pain due to distal tibia fracture, we have observed neuronal and glial
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parallels of central sensitization. In particular, we have
reported biochemical and molecular correlates of allodynia,
hyperalgesia, and latent sensitization in terms of altered
glutamatergic tone in the SC4,5 as well as neuroinflammation
and glial activation.6 Furthermore, we have described broad
spinal transcriptomic changes as the animals progress from
an acute to a more chronic stage of pain.7 These observa-
tions have prompted us to look at the ECM where these cells
function, with the supposition that SC cellular plasticity
requires a plastic ECM niche.8
Our central hypothesis is that chronic pain is associated
with disturbed spinal ECM homeostasis. In the current
study, we took aim at examining the role of specific SC
matrix remodeling enzymes following peripheral injury.
Using biochemical, behavioral, and molecular tools, we
demonstrate a key role for spinal MMP8 in regulating pain
after peripheral trauma.
Methods
All testing and analysis was blinded to the identity and
experimental condition of the animal/tissue.
Animals
Male C57BL/6J mice aged 12–14 weeks were purchased
from a commercial supplier (Jackson Labs, Sacramento,
CA, USA) and were allowed to habituate to the animal
facility for a minimum of 10 days prior to the experiments.
Mice were housed in groups of 4 on a 12-hr light/dark
cycle and an ambient temperature of 22±3 °C, with food
and water available ad libitum. All animal procedures and
experimental designs were approved by the Veterans
Affairs Palo Alto Health Care System Institutional
Animal Care and Use Committee (Palo Alto, CA, USA)
and followed the “animal subjects” guidelines of the
International Association for the Study of Pain.
Tibia fracture and cast immobilization
Following the random allocation to the control or the
fracture/cast group, mice were anesthetized with 1.5%
isoflurane and underwent a distal tibial fracture in the
right leg followed by cast immobilization as previously
described.4 Casts were removed 3 weeks after surgery
under brief isoflurane anesthesia.
Behavioral testing of tactile allodynia
Mice were habituated to handling by the experimenter for
a few minutes each day for 7 days before initiation of the
behavioral tests. Calibrated monofilaments (Stoelting Co.,
Wood Dale, IL, USA) were applied to the plantar surface
of the hind paw and the 50% threshold to withdraw
(grams) was calculated as previously described.9
Biochemical analysis
Mice were euthanized under isoflurane anesthesia, and
ipsilateral lumbar SCs were quickly isolated. Tissues
were homogenized using T-PER Protein Extraction
Reagent (cat. # 87793; Thermo Scientific, Waltham, MA,
USA) in the presence of proteinase and phosphatase inhi-
bitors (cat. # 04906837001; Roche Applied Science, Palo
Alto, CA, USA) and centrifuged at 12,000 g for 4 mins at
4°C. Supernatant fractions were then frozen at 80°C until
use. An aliquot was subjected to protein assay (cat. # 500-
0001; Bio-Rad, Hercules, CA, USA) to normalize protein
levels. The MMP8 ELISA kit was used as per manufac-
turer’s instructions (cat. # ab206982; abcam, USA).
MMP8 downregulation
Pharmacological inhibition of MMP8
Mice were randomized to receive either intraperitoneal
injections of vehicle (saline +1%DMSO) or the specific
MMP8 inhibitor, M8I (3R)-(+)-[2-(4-methoxybenzenesul-
fonyl)-1,2,3,4-tetrahydroisoquinoline-3-hydroxamate,
dose=1mg/kg] (cat. # CAS 236403-25-1; Calbiochem, San
Diego, CA, USA). Daily injections of vehicle or MMP8
inhibitor spanned 14 days, starting at 5 weeks post-injury.
CNS penetration of the compound was verified by western
blot analysis, demonstrating a decreased level of MMP8 in
CNS tissues (data not shown).
Lentiviral delivery of shRNA
We manipulated MMP generation capacity in the SC using
short hairpin RNA (shRNA) administration through lentiviral
delivery. Lentiviral particles for mouse MMP8-specific
shRNA (MMP8 Mission® shRNA; 1 × 106 TU/mL;
pLKO.1 vector) or nontarget shRNA control (Mission®
pLKO.1 puro non-target shRNA control) were purchased
commercially (Sigma Aldrich, St Louis, MO, USA).
The sequence for MMP8-specific shRNA is:
CCGGGCCTTGATGTACCCAAACTATCTCGAGATAGT-
TTGGGTACATCAAGGCTTTTTG. Three weeks after
injury, mice were allocated to random groups to receive
a single intrathecal injection (isoflurane anesthesia, injection
volume =5 µl) of lentivirus deliveringMMP8-specific shRNA
or nontarget shRNA control. This method of CNS MMP8
downregulation has been previously validated by our group.3
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Lentiviral delivery was confirmed via visual inspection
following the spinal administration of a pLKO.1-CMVtGFP
vector with a nontarget SHC016 shRNA sequence (Sigma
Aldrich) which was used as described above.
Statistical analysis
The data for biochemical measurements were analyzed by
unpaired 2-tailed t-tests. F tests were carried out to mea-
sure differences of variance between groups. Behavioral
data were analyzed by two-way ANOVA followed by
Sidak post-hoc test for multiple comparisons. All data
are presented as mean ± SEM and for all analyses,
p<0.05 were taken to be significant.
Results
Biochemical dysregulation of the ECM is
observed after injury
To assess the overall integrity of the SC ECM after per-
ipheral injury, protein measurements of MMP8 were car-
ried out. Compared to control mice, injured mice displayed
decreased levels of ipsilateral SC MMP8 (F=3.7, p=0.02)
3 weeks after injury (Figure 1A).
Pharmacological inhibition of MMP
ameliorates mechanical allodynia after
injury
In order to link biochemical ECM stability to the phenotype of
ongoing pain after injury, we systemically treated mice with
a selective MMP8 inhibitor for 2 weeks. Behavioral measures
of tactile allodynia at the 7-week timepoint demonstrate an
amelioration of mechanical sensitivity in the group that was
treated with theMMP8 inhibitor. Compared to vehicle-treated
injured mice, M8I-treated injured mice showed an increase in
mechanical threshold values on the ipsilateral hindpaw (mean
difference=−0.38±0.18, Figure 1B).
shRNA downregulation of spinal MMP8
results in a progressive increase in
mechanical thresholds after injury
In order to ascertain the role of MMP8 in spinal tissues,
we complemented our systemic M8I administration studies
with intrathecal injections of MMP8-downregulating
shRNA using lentiviral vectors. Our data show that
a single injection at the 3w timepoint was sufficient to
elicit improvements in mechanical hypersensitivity.
Compared to injured mice treated with control-shRNA,
injured mice treated with MMP8-downregulating shRNA
showed increased mechanical thresholds on the ipsilateral
hindpaw at the 6- (mean difference=0.59±0.2) and 7-
(mean difference=0.61±0.2) week timepoints (Figure 1C).
Discussion
In this report, we provide evidence for a novel spinal
mechanism that may support the transition of acute to
chronic pain. Our data show that spinal ECM dysregulation
in the form of increased MMP8 is observed following per-
ipheral trauma and that its normalization can reverse pain
hypersensitivity in a mouse model of tibia fracture, thereby
proposing a novel mechanism of pain-related SC plasticity.
Recent studies have outlined a role for MMP8 following
frank injury to the SC. Acute MMP8 upregulation was
recently demonstrated in a model of SC compression, and
its inhibition was linked to neuroprotective effects in rats;10
similarly, clinical studies have shown the upregulation of
serum MMP8 levels in patients with SC injury.11,12
However, to our knowledge, this is the first report of spinal
MMP8 involvement in chronic pain due to peripheral trauma.
The CNS ECM is a dynamic entity that continues to
change in adulthood. A wealth of studies support the
hypothesis that CNS damage is accompanied by profound
ECM alterations: traumatic spinal injury and multiple
sclerosis are both paralleled by an upregulation in chon-
droitin sulfate proteoglycans, key components of the CNS
ECM13 that are generally linked to restricted neuronal
plasticity.14 Additionally, heparin sulfate proteoglycan
involvement has been demonstrated in neurodegenerative
disorders such as Alzheimer’s disease and Parkinson’s
disease.15 While chronic pain is often the result of an
injury to the periphery rather than CNS insult, significant
SC and brain neuroplasticity is observed in various chronic
pain conditions,16 suggesting the involvement of a plastic
ECM. This direction is quickly gaining traction: for exam-
ple, a recent manuscript describes the spinal upregulation
of the astrocyte-secreted ECM protein thrombospondin-4
and its role in the development of aberrant excitatory
synaptogenesis and peripheral neuropathy in rats.17
Finally, in our recent manuscript,3 we show structural
and biochemical alterations in the hippocampal ECM that
are linked to pain, cognitive dysfunction, and cellular
plasticity in a mouse model of chronic pain.
How does a dysregulated ECM contribute to pain chron-
ification? We propose the following possible mechanisms:
first, the degradation of ECM structural components could
result in a less rigid matrix that is no longer able to support
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Figure 1 Distal tibial fracture is associated with increased levels of MMP8 in the ipsilateral lumbar spinal cord (A). Both the systemic pharmacological (M8I administration
(B) and localized genetic (shRNA administration, C) downregulation of MMP8 resulted in improvements in mechanical sensitivity. n=5–12 mice/group.*p<0.05. Error bars
indicate the SE of the mean.
Abbreviations: MMP8, matrix metalloproteinase 8; M8I inhibitor of matrix metalloproteinase 8; shRNA, short hairpin RNA.
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the cytoarchitectural changes in neuronal dendrites,3 thus pre-
venting adaptive neuronal plasticity. Second, a dysregulated
ECM might be deficient in the storage of pronociceptive
cytokines, thus making them more available to neurons and
glia. In particular, proteoglycans have been shown to interact
with cytokines and modify their binding to cell surface recep-
tors as well as their storage within the ECM.18 Third, it is
possible that the perineuronal net, a specialized ECM that
predominantly surrounds inhibitory interneurons, is affected,
thereby resulting in destabilized inhibitory interneurons.
Diminished inhibition in the SC dorsal horn is a well-studied
mechanism of chronic pain.19 Fourth, excessive proteolytic
activity byMMPs could result in damage to tight junctions and
the subsequent compromise of the blood–SC barrier.10
Increased blood-SC permeability has been reported in models
of peripheral neuropathy.20 Future studies targeting each of
these hypotheses will be undertaken.
The current report is the first statement of SC ECM invol-
vement in pain regulation. While we show that MMP8 down-
regulation is sufficient in ameliorating the pain phenotype,
further studies localizing these ECM changes, both to specific
SC regions and to specific cell types, are needed.
Understanding ECM mechanisms of CNS plasticity
can significantly improve our understanding of chronic
pain. Additionally, it can provide valuable tools in research
methodology: for instance, a recent study described an
approach to magnetomechanical neuromodulation of dor-
sal root ganglion neurons via a 3D magnetic hyaluronic
acid hydrogel.21 Finally, this direction can offer novel
therapeutic venues where relevant ECM components,
rather than cell types, can be targeted. Such interventions,
administered after injury, have the potential to prevent the
chronification of pain, thereby greatly enhancing recovery.
Disclosure
The authors report no conflicts of interest in this work.
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